Recent findings have indicated that the role of IL-17 in tumor development is controversial, and IL-17 could promote the induction of MDSCs at a tumor site and enhance the suppressive function of MDSCs on T cell proliferation [48–52]. The gene discussed is IL17A; the disease is neoplasm.